Fibroblast activation in response to TGFβ1 is modulated by co-culture with endothelial cells in a vascular organ-on-chip platform.
Saved in:
| Title: | Fibroblast activation in response to TGFβ1 is modulated by co-culture with endothelial cells in a vascular organ-on-chip platform. |
|---|---|
| Authors: | Luu RJ; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Hoefler BC; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Gard AL; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Ritenour CR; Pfizer Inc., Groton, CT, United States., Rogers MT; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Kim ES; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Coppeta JR; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Cain BP; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Isenberg BC; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Azizgolshani H; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Fajardo-Ramirez OR; Laboratory for Systems Mechanobiology, Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States., García-Cardeña G; Laboratory for Systems Mechanobiology, Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States., Lech MP; Pfizer Inc., Cambridge, MA, United States., Tomlinson L; Pfizer Inc., Cambridge, MA, United States., Charest JL; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Williams C; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States. |
| Source: | Frontiers in molecular biosciences [Front Mol Biosci] 2023 Jul 28; Vol. 10, pp. 1160851. Date of Electronic Publication: 2023 Jul 28 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653173 Publication Model: eCollection Cited Medium: Print ISSN: 2296-889X (Print) Linking ISSN: 2296889X NLM ISO Abbreviation: Front Mol Biosci Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
